attachment
attachment
attachment
attachment

CT scan of pt, probable daignosis and treatment

Reading File
Finding Sources
Finding Sources
Searching PubMed

colonic wall thickening cecum ascending colon inflammatory etiology diagnosis

Reading File
Finding Sources
Finding Sources
Searching PubMed

intestinal tuberculosis diagnosis treatment

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Based on the CT report and textbook evidence, here is a thorough clinical analysis:

CT Abdomen & Pelvis - Clinical Analysis

Patient: Shrushti Anilsing Deshmukh, 20-year-old female Study: CECT Abdomen & Pelvis, Kamalnayan Bajaj Hospital, 08-Jul-2026

Key CT Findings

FindingDetail
Long segment circumferential colonic wall thickeningCecum + ascending colon + transverse colon, max 5.1 mm
No luminal narrowingPresent scan
No pericolonic lymphadenopathyPresent scan
Multiple subcentimeter calcified hepatic granulomasScattered throughout liver parenchyma
No ascites-
No retroperitoneal lymphadenopathy-
Liver, GB, pancreas, spleen, kidneys, ureters, bladderAll normal

Probable Diagnosis: Intestinal Tuberculosis (Colonic TB)

This is the most likely diagnosis given the clinical and radiological pattern, especially in a young Indian female. Here is the reasoning:

Why Intestinal TB?

  1. Distribution pattern - Cecum + ascending colon + transverse colon involvement is classic for colonic TB. The Sleisenger & Fordtran textbook states that the ileum and cecum are the most common sites (75% of cases), and colonic TB can show "extensive involvement of the cecum, ascending, and transverse colon."
  2. Circumferential wall thickening - Consistent with the ulcerohypertrophic form of intestinal TB (30% of cases), which combines mucosal ulceration with healing and fibrosis.
  3. Calcified hepatic granulomas - Multiple subcentimeter calcified granulomas in the liver are a hallmark of healed hepatic TB (or histoplasmosis in endemic areas, but TB is far more likely in India). These indicate prior or concurrent mycobacterial infection and strongly support a TB etiology.
  4. Young patient in an endemic region - India has the world's highest TB burden; a 20-year-old presenting with colonic inflammation + hepatic granulomas is highly suspicious.
  5. No lymphadenopathy on CT - Note that enlarged/necrotic mesenteric nodes are a major CT feature of intestinal TB, but their absence does not exclude the diagnosis (early disease or treated TB).

Differential Diagnoses

DiagnosisSupporting FeaturesAgainst
Intestinal TBCecal + right colon involvement; hepatic granulomas; endemic region; young ageNo massive lymphadenopathy, no luminal narrowing
Crohn's DiseaseCircumferential wall thickening; long segment involvementNo terminal ileum disease mentioned; no skip lesions; no fat wrapping; calcified granulomas point away
Ulcerative ColitisLong segment colitisUC is continuous from rectum upward - not right-sided/patchy
Infectious Colitis (Ameba, Yersinia, Schistosoma)Cecal involvementCalcified hepatic granulomas strongly suggest TB/granulomatous disease
Ischemic ColitisWall thickeningVery unlikely at age 20

Recommended Diagnostic Workup

Immediate (to confirm diagnosis)

  • Colonoscopy with biopsy - the most important investigation. Biopsy for:
    • Histopathology (look for caseating granulomas)
    • AFB (Ziehl-Neelsen) stain
    • Mycobacterial culture and drug sensitivity testing
    • TB-PCR on biopsy tissue (sensitivity ~65%)
  • Mantoux test / IGRA (QuantiFERON-TB Gold) - to detect M. tuberculosis infection
  • Chest X-ray / HRCT chest - to look for concurrent pulmonary TB
  • Sputum AFB smear + culture (if pulmonary involvement suspected)
  • Stool AFB culture
  • CBC, ESR, CRP, LFT, serum albumin
  • HIV serology (immunocompromise workup)
  • Serum ADA (Adenosine Deaminase) - elevated in TB
  • If granulomas found on biopsy - ACE levels to also rule out sarcoidosis

Treatment

If Intestinal TB confirmed:

Standard anti-TB therapy (same as pulmonary TB) per National TB Elimination Programme (NTEP) / WHO guidelines:
Intensive Phase (2 months):
  • Isoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E)
  • Written as 2HRZE
Continuation Phase (4 months):
  • Isoniazid (H) + Rifampicin (R)
  • Written as 4HR
Total duration: 6 months (same as pulmonary TB)
Note: If response to therapy occurs (within 2 weeks typically), this can also be used as a confirmatory therapeutic trial. However, culture confirmation is strongly preferred before initiating treatment when possible.

Additional management:

  • Nutritional support - correct malnutrition/hypoalbuminemia
  • Pyridoxine (Vitamin B6) - given alongside isoniazid to prevent peripheral neuropathy (10 mg/day)
  • Monitor LFTs monthly for drug-induced hepatotoxicity (especially with INH + RIF + PZA)
  • Public health notification - TB is a notifiable disease
  • Contact tracing of household members

If Crohn's Disease confirmed (on biopsy):

  • 5-ASA (mesalazine) for mild disease
  • Corticosteroids for moderate-active disease
  • Immunomodulators (azathioprine, 6-MP) for maintenance
  • Biologics (anti-TNF) for severe/refractory disease
  • Important caveat: Do NOT start steroids or immunosuppressants before excluding TB - this can cause fatal dissemination of occult TB.

Summary

The combination of long-segment right colonic wall thickening + multiple calcified hepatic granulomas in a 20-year-old Indian female is highly characteristic of intestinal tuberculosis with hepatic involvement. The radiologist's suggestion of "inflammatory etiology" is apt, and colonic TB tops the differential.
Colonoscopy with biopsy is the mandatory next step before any treatment is initiated.
References: Sleisenger and Fordtran's Gastrointestinal and Liver Disease (9780323609623) - Tuberculosis of the Intestinal Tract; Jha et al. 2023 - Evidence-based approach to diagnosis and management of abdominal tuberculosis; Choudhury et al. 2023 - Differentiating GI tuberculosis and Crohn's disease

Disclaimer: This analysis is for educational and clinical decision support purposes. The treating physician should integrate this with the full clinical history, examination findings, and local epidemiology before making management decisions.
This is a shared conversation. Sign in to Orris to start your own chat.